Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study

Autor: Wafaa El-Sadr, David A. Cooper, Nicki Smith, Gregg Larson, Patty Bollenbeck, John Worley, Chloe Orkin, Daniela Gey, Andrzej Horban, Maxime Seligmann, Greg Thompson, Ray Nelson, David Courtney-Rodgers, Valerie Beral, Adriana Sanchez, John Chuah, Karoline Jensen, Ann M. Labriola, Jens D Lundgren, Ronald J. Prineas, Marcelo H. Losso, Richard J. Price, Billy Pick, Maria C. Rodriguez-Barradas, Norman Markowitz, J Vera, Bitten Aagaard, Karen Hennessey, Gustavo Lopardo, Cate Carey, Daniel E. Nixon, Eileen Denning, Liselotte Borup, Barbara E. Murray, Richard E. Chaisson, Christopher Hill, Kamal Mansinho, Martin J. Wiselka, Shawn K. Brown, Hakima Himmich, Jo Watson, Fionna Van Hooff, Janet Darbyshire, Frank S. Rhame, Jessica Horton, Court Pederson, Jesper Grarup, John F. Modlin, Jonathan P. Anderson, Dwight E. Peavy, Claire Rappoport, Merrie Harrison, Siu Fun L. Quan, Barbara Standridge, Julie Eckstrand, Pacharee Kantipong, Fred M. Gordin, Jorge A. Tavel, Ana Martinez, Juan Carlos López, Lisa Fosdick, Ploenchan Chetchotisakd, Ian Weller, James D. Neaton, Doug Thomas, Elizabeth Finley, Simon Portsmouth, Mirta Valdez, Waldo H. Belloso, Giuseppe Tambussi, Nicholas I. Paton, Vanita Costas, Nafisah Braimah, Sergio H. Lupo, Simon Collins, Terri Schultz, Siegfried Schwarze, David Haerry, Kien Quan, Daniel Duprez, James H. Sampson, Thomas R. Fleming, Kyung Mann Kim, Eric A. Krum, Gregory M. Anstead, Matthew Bidwell Goetz, Marcelo Wolff, Deborah Wentworth, Stefano Rusconi, Søren Reilev, Abdel Babiker, Eleanor King, Francisco Antunes, Sean Emery, David Orth, Per O. Jansson, Lawrence Fox, Martin Fisher, Mary Anne Luzar, Alan R. Lifson, David Mollerup, Rick Davey, Alan Winston, Jenny Hoy, Kiat Ruxrungtham, Michael Meulbroek, Nicole Wyman, Judith Bebchuk, José M. Gatell, Alain G. DuChene, David Munroe, Roberto C. Arduino, George Perez, Mark James Kelly

Publikováno v: PLoS ONE
PLoS ONE, Vol 5, Iss 2, p e9334 (2010)
PloS one, vol 5, iss 2
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona

BACKGROUND: The Study of Aldesleukin with and without antiretroviral therapy (STALWART) evaluated whether intermittent interleukin-2 (IL-2) alone or with antiretroviral therapy (ART) around IL-2 cycles increased CD4(+) counts compared to no therapy.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e02e4546eb935338438cf232f726b50
http://ora.ox.ac.uk/objects/uuid:aef3f5ca-a828-42a6-b782-9f2e9ba8babc

Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count≥300 cells/μL who were assigned to 7.5 MIU interleukin-2.

Autor: Fox, Zoe¹ z.fox@pcps.ucl.ac.uk

Publikováno v: HIV Medicine. Mar2007, Vol. 8 Issue 2, p112-123. 12p.